Matches 1 - 50 out of 132 1 2 3 >
Match Document Document Title
7259153 Drug formulation and delivery using crystalline methylated cyclodextrins  
The present invention is directed to pharmaceutical compositions containing crystalline methylated cyclodextrins, which enhance the solubility of the pharmaceutically active agent or agents of the...
7115586 Non-inclusion cyclodextrin complexes  
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
7091335 Derivatized reduced malto-oligosaccharides  
Disclosed are derivatized malto-oligosaccharides and methods for the preparation thereof. In accordance with the disclosed invention, a malto-oligosaccharide is hydrogenated to thereby obtain a...
7087709 Polymers for delivering nitric oxide in vivo  
Disclosed are novel polymers derivatized with at least one —NO x group per 1200 atomic mass unit of the polymer. X is one or two. In one embodiment, the polymer is an S-nitrosylated polymer and...
7030237 Method and equipment for continuous and selective inclusion separation  
In a reaction system having at least two liquid-liquid interfaces between an organic phase of raw material containing a compound(s) to be separated and an aqueous phase of an aqueous solution of...
7005513 Functionalized glycosaminoglycan polymer and medical instruments and drugs by using the same  
The present invention provides a functionalized polymer which can be used extensively in the field of medical drugs as well as medical devices and which is obtainable in an organic synthetic manner...
7005426 Folic acid-polysaccharide complex, its preparation method and pharmaceutical composition containing the same as active component  
The present invention relates to folic acid-polysaccharide complexs and method of preparation thereof, more particularly relates to folic acid-Dextran complexs, method of preparation thereof,...
7001893 Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof  
The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for...
6998479 Derivatives of cyclodextrins  
The present invention is directed to novel aminooxy-cyclodextrin derivatives of the formula (1): CD—(X—Y—ONH 2 ) n , wherein CD is mono- or polydeoxy α-, β-, or γ-cyclodextrin, carrying in...
6982256 Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration  
The invention relates to new formulations for improving the local tolerance of intravenously administered 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-b enzoylguanidine or one of the...
6884885 Production of cyclodextrin complexes  
The process entails increasing the concentration of cyclodextrin to 15% (w/w) and above to form complexes through a precipitation process in order to increase the yield of complexes, increase the...
6878695 Compositions comprising cyclodextrin derivatives  
A stable composition for removing unwanted molecules from a surface comprises low-degree of substitution cyclodextrin derivatives. The compositions are suitable for capturing unwanted molecules...
6864246 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae  
The invention concerns more particularly dodecylthio-phenylacetanilide derivative complexes such as (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phe nylacetanilide or related...
6858723 Amphiphile cyclodextrins, preparation and use thereof for solubilizing organized systems and incorporating hydrophobic molecules  
The invention provides cyclodextrin derivatives that may be used to transport hydrophobic molecules for pharmaceutical or cosmetic applications, by forming organised systems in an aqueous medium,...
6835718 Biocleavable micelle compositions for use as drug carriers  
This invention discloses compositions and methods for preparing biocleavable or biodegradable micelle compositions for carrying and releasing drugs and other active agents for therapeutic or other...
6818630 Biologically active materials  
The present disclosure concerns biologically active materials, particularly materials that comprise a biodegradeable polymer linked to a biologically active agent. The disclosure further concerns...
6699849 Cyclodextrin complexes of benzodiazepines  
Methods for enhancing the complexation efficiency of a drug with cyclodextrin and for enhancing the availability of a drug following administration of a cyclodextrin-drug complex.
6590096 Process for the production of polysaccharide beads  
The present invention relates to a method for producing porous polysaccharide beads, comprising: (a) mixing a water-based solution of a polysaccharide under stirring with an essentially...
6528629 Malto-oligosaccharide derived glycosides  
Disclosed is a method for preparing a malto-oligosaccharide derived glycoside. Generally, the method comprises providing a malto-oligosaccharide and glycosylating the malto-oligosaccharide with an...
6475803 Cyclodextrin derivatives and measurement of water contamination degree using the same  
A cyclodextrin derivative is an X-hydroxynaphthalene-Y-amidated cyclodextrin formed by subjecting a starting cyclodextrin to an addition reaction with A-hydroxyl-B-carboxyl naphthalane and used for...
6355627 Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same  
The invention has an object of providing a hinokitiol which is not damaged in the antibacterial activity and improved in the water solubility, heat stability (anti-sublimation characteristics) and...
6316613 Chiral separation of pharmaceutical compounds with charged cyclodextrins using capillary electrophoresis  
The separation of enantiomeric pairs of compounds by capillary electrophoresis using highly sulfated α-, β-, and γ-cyclodextrins as chiral selectors is described herein. These charged...
6204256 Acylated cyclodextrin derivatives  
A cyclodextrin derivative, wherein at least 60 percent of the free hydroxy groups of said cyclodextrin are acylated with acyl groups where at least one of said acyl groups comprise a free...
6197951 Starch graft copolymer blast media  
The invention discloses a starch graft poly(meth)acrylate blast media which is effective in paint removal. The media is superior to a physical blend of the components (i.e., starch and acrylic...
6127530 Method for the reduction of oxygenated compounds of rhenium or technetium  
The present invention relates in general to a method for the reduction of oxygenated compounds of rhenium and technetium and in particular to the reduction of perrhenate or pertechnetate ions. More...
6113880 Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging  
The invention relates to polyrotaxanes that contain metal complexes or iodine-containing benzene derivatives as imaging components for MRT diagnosis and x-ray diagnosis.
6103892 Catalyst that oxidizes steroids and other substrates with catalytic turnover  
The present invention provides a metalloporphyrin catalyst represented by the structure: ##STR1##
6103885 Method of making amide modified carboxyl-containing polysaccharide and fatty amide-modified polysaccharide so obtainable  
The Invention pertains to a process for the amidation of a material having at least one carboxyl-containing polysaccharide. The provided process involves a first step in which the carboxyl groups...
6068831 Pseudopolyrotaxanes  
The invention relates to new metal complex-containing or iodine-containing benzene derivatives that contain pseudopolyrotaxanes. They are valuable compounds for diagnosis. The pseudopolyrotaxane...
6060597 Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases  
A cyclic oligosaccharide or salts thereof comprising glucoses bound cyclically via α-1,6-linkages and having at least one S-oxo acid group bound, and ana gent for preventing or treating retroviral...
5925534 Method for measuring LDL-cholesterol  
The amount of cholesterol in low density lipoproteins in a sample can be measured by contacting the sample with one or more reagent solutions to carry out the reaction in the presence of a...
5840881 Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility  
A composition is disclosed comprising a water-insoluble or slightly water-soluble compound and a branched cyclodextrin-carboxylic acid. The branched cyclodextrin-carboxylic acid significantly...
5840714 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, pharmaceutical preparations containing said inclusion complexes and methods for using same  
Inclusion Complexes of Racemic Ibuproxam and of Optically Active Ibuproxam with Cyclodextrin Derivatives, Process for the Preparation Thereof, Pharmaceutical Preparations Containing these Inclusion...
5834446 Nerve process growth modulators  
Nerve process growth modulation can be achieved using derivatized cyclodextrins. Processes for making sulfated and aminated β-cyclodextrin derivatives are also described in which a compound of the...
5824798 Genetically engineered modification of potato to obtain amylopectin-type starch  
Genetically engineered modification of potato for suppressing formation of amylose-type starch is described. Three fragments for insertion in the antisense direction into the potato genome are also...
5814472 Measurement of LDL-cholesterol  
Cholesterol in low density lipoproteins can be measured specifically and precisely by optically measuring a reaction product of a living sample with cholesterol oxidase or cholesterol dehydrogenase...
5811236 Electrochemiluminescent rhenium moieties and methods for their use  
Electrochemiluminiscent moieties having the formula Re(P) m (L 1 ) n (L 2 ) o (L 3 ) p (L 4 ) q (L 5 ) r (L 6 ) s ! t (B) u wherein P is a polydentate ligand of Re; L 1 , L 2 , L 3...
5800602 Use of inclusion compounds of cyclic polysaccharides as charge control agents  
Inclusion compounds consisting of a host compound, which is a cyclically linked polysaccharide having 3 to 100 monomeric saccharide units and forming a cavity in its molecular framework, and of one...
5789569 Isothiocyanated cyclodextrin derivative  
The present invention relates to an isothiocyanated cyclodextrin derivative which can label various kinds of organic compounds containing an amino group as their functional group. In some...
5780619 Starch graft poly(meth)acrylate blast media  
The invention discloses a starch graft poly(meth)acrylate blast media which is effective in paint removal. The media is superior to a physical blend of the components (i.e., starch and acrylic...
5776914 Prevention of hemolysis  
Disclosed are compositions and methods for preventing or substantially inhibiting the hemolytic activity of hemolysis inducing agents. The methods and compositions are based on the use of an...
5773227 Bifunctional chelating polysaccharides  
This invention describes bifunctional polysaccharides conjugated to both a chelating group suitable for the selective complexation of metal cations, and a targeting peptide specific for a cellular...
5763598 Branched cyclodextrins and method for producing them  
Disclosed are novel branched cyclodextrins having any of an N-acetylglucosamine group, a glucosaminyl group, an N-acetylgalactosaminyl group and a galactosaminyl group as bonded to the hydroxyl...
5760017 Cyclodextrin derivatives usable in particular for solubilizing hydrophobic chemical compounds such as medicaments and their preparation process  
The invention relates to novel cyclodextrin derivatives according to formula: ##STR1## in which R 1 represents OH or NH(CH 2 ) p OH, n is equal to 5, 6 or 7 and p is an integer from 2 to 6, it...
5744165 Nimesulide salt cyclodextrin inclusion complexes  
Inclusion complexes of nimesulide alkali and alkaline earth salts with cyclodextrins and cyclodextrin derivatives are disclosed. Compositions containing the inclusion complexes, processes for the...
5731296 Selective vasodilation by continuous adenosine infusion  
This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human...
5728823 Cyclodextrin derivatives having at least one nitrogen-containing heterocycle, their preparation and use  
Reactive cyclodextrin derivatives have at least one nitrogen-containing heterocycle. The reactive cyclodextrin derivatives include at least one nitrogen-containing heterocycle having at least one...
5698535 SIN-1A cyclodextrin inclusion complexes  
New inclusion complexes which are stable in their so-lid state formed of SIN-1A and cyclodextrins or cyclodextrin derivatives and optionally also containing ions as catalyst or stabilizer. The...
5631244 mono(6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue, process for their preparation and their uses  
Mono (6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue. These derivatives correspond to the following general formula: ##STR1## in which: CD...
5587466 Conductive polymer doped by a sulphonated cyclodextrin salt and device for obtaining and/or supplying an active substance incorporating said polymer  
Conductive polymer doped by a sulphonated cyclodextrin salt and device for obtaining and/or supplying an active substance incorporating said polymer. The dopant used has the following formula (I):...
Matches 1 - 50 out of 132 1 2 3 >